What mutations mean?

R

RiRi

Guest
This I know has been talked about before. (If there is a way to look at old posts someone please clue me in.)
But what are the most common mutations for CF'ers. I see the Delta F508 mentioned aslot here but what exactly does it represent? Are any ones worse that others?


Thanks.
 
R

RiRi

Guest
This I know has been talked about before. (If there is a way to look at old posts someone please clue me in.)
But what are the most common mutations for CF'ers. I see the Delta F508 mentioned aslot here but what exactly does it represent? Are any ones worse that others?


Thanks.
 
R

RiRi

Guest
This I know has been talked about before. (If there is a way to look at old posts someone please clue me in.)
But what are the most common mutations for CF'ers. I see the Delta F508 mentioned aslot here but what exactly does it represent? Are any ones worse that others?


Thanks.
 

cheerfull

New member
My daughter has the same thing ddf508 and she is 11 months old1 I was wondering the same thing, How do I know how bad that is, will that depond on how long she will live? So meny QA's
 

cheerfull

New member
My daughter has the same thing ddf508 and she is 11 months old1 I was wondering the same thing, How do I know how bad that is, will that depond on how long she will live? So meny QA's
 

cheerfull

New member
My daughter has the same thing ddf508 and she is 11 months old1 I was wondering the same thing, How do I know how bad that is, will that depond on how long she will live? So meny QA's
 
M

Mommafirst

Guest
I am absolutely certain someone else on here will have better information for you. But from my understanding mutations are grouped into classes. I think that the combination of classes one has can be a predictor of pancreatic sufficiency/insufficiency, but that lung functioning is not necessarily correlated with mutation combinations. There have been some articles discussing the likelihood of a modifier gene that would have more information about lung involvement and progression, but I don't know that this has necessarily been discovered. I do know that two siblings can have the same two mutations and have completely different progressions. So much so that I know of a family with three kids, same genes. Two of the children died twenty years ago in their early teens and the third is still alive and doing fabulously in her late thirties. So I'm pretty sure that mutation and even class alone is not a clear predictor.

BTW if you want to search previous posts, go to the search bar on the left and type in the topic.

Hope this helps.
 
M

Mommafirst

Guest
I am absolutely certain someone else on here will have better information for you. But from my understanding mutations are grouped into classes. I think that the combination of classes one has can be a predictor of pancreatic sufficiency/insufficiency, but that lung functioning is not necessarily correlated with mutation combinations. There have been some articles discussing the likelihood of a modifier gene that would have more information about lung involvement and progression, but I don't know that this has necessarily been discovered. I do know that two siblings can have the same two mutations and have completely different progressions. So much so that I know of a family with three kids, same genes. Two of the children died twenty years ago in their early teens and the third is still alive and doing fabulously in her late thirties. So I'm pretty sure that mutation and even class alone is not a clear predictor.

BTW if you want to search previous posts, go to the search bar on the left and type in the topic.

Hope this helps.
 
M

Mommafirst

Guest
I am absolutely certain someone else on here will have better information for you. But from my understanding mutations are grouped into classes. I think that the combination of classes one has can be a predictor of pancreatic sufficiency/insufficiency, but that lung functioning is not necessarily correlated with mutation combinations. There have been some articles discussing the likelihood of a modifier gene that would have more information about lung involvement and progression, but I don't know that this has necessarily been discovered. I do know that two siblings can have the same two mutations and have completely different progressions. So much so that I know of a family with three kids, same genes. Two of the children died twenty years ago in their early teens and the third is still alive and doing fabulously in her late thirties. So I'm pretty sure that mutation and even class alone is not a clear predictor.

BTW if you want to search previous posts, go to the search bar on the left and type in the topic.

Hope this helps.
 

CFHockeyMom

New member
First thing to note is that DF508 is the most common but it's class is not the most "severe". It is a class II mutation.

Here's some info I copied from another post about the various classes...

Class I mutations lead to defects in the synthesis of stable CFTR mRNA transcripts resulting in absence of the CFTR protein. About half of all mutations in CFTR (encompassing premature termination, exon skipping, aberrant mRNA splicing, and frameshifts) are thought to fall into this class and result in complete loss of CFTR protein/function.

Class II mutations, including F508, complete protein translation but produce an abnormal protein that fails to escape the endoplasmic reticulum. Little or no CFTR reaches the plasma membrane, and the absence of all surface CFTR results in a severe phenotype. It is being increasingly recognized that mutations in unrelated genes can create defective proteins, which fail to traffic properly through the cell. Classically, missense mutations creating an abnormal protein were thought to be relatively benign or less consequential than nonsense mutations (null) or large deletions. This is no longer strictly the case because examples from CF and other inherited disorders demonstrate that a synthesized protein that fails to mature along the normal biosynthetic pathway often becomes quite destructive (7).

Class III mutations disrupt activation and regulation of CFTR at the plasma membrane. Thus biosynthesis, trafficking, and processing are undisturbed, but the channel may be defective with respect to ATP binding and hydrolysis, or phosphorylation. Mutations, such as G551D, tend to be associated with a severe phenotype.

Class IV mutations affect chloride conductance or channel gating and thus result in reduced chloride current. As might be expected, mutations in this class, such as R117H or P574H, are thought to confer a milder phenotype.

Class V mutations reduce the level of normal CFTR protein by alterations in the promoter or by altering splicing. Currently it is thought that a reduction in mRNA to less than 10% of normal results in disease in CF. Examples of Class V mutations include 3849 + 10kb CT, A455E, and 5T.


Here's some info that Allie posted about how different classes "interact"...

Now, I know this is just one article, but I found it really interesting, in france, they did research of CFers with class I /I or class II/I combinations. They found a much higher likelihood of severe pancreatic disease (which we knew), but the interestig thing was they found that people with a class one mutation were more likely to be colonized with pseudo. Interesting.

<a target=_blank class=ftalternatingbarlinklarge href="http://www.pslgroup.com/dg/214BBE.htm">http://www.pslgroup.com/dg/214BBE.htm</a>

Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival .



Hope this helps.
 

CFHockeyMom

New member
First thing to note is that DF508 is the most common but it's class is not the most "severe". It is a class II mutation.

Here's some info I copied from another post about the various classes...

Class I mutations lead to defects in the synthesis of stable CFTR mRNA transcripts resulting in absence of the CFTR protein. About half of all mutations in CFTR (encompassing premature termination, exon skipping, aberrant mRNA splicing, and frameshifts) are thought to fall into this class and result in complete loss of CFTR protein/function.

Class II mutations, including F508, complete protein translation but produce an abnormal protein that fails to escape the endoplasmic reticulum. Little or no CFTR reaches the plasma membrane, and the absence of all surface CFTR results in a severe phenotype. It is being increasingly recognized that mutations in unrelated genes can create defective proteins, which fail to traffic properly through the cell. Classically, missense mutations creating an abnormal protein were thought to be relatively benign or less consequential than nonsense mutations (null) or large deletions. This is no longer strictly the case because examples from CF and other inherited disorders demonstrate that a synthesized protein that fails to mature along the normal biosynthetic pathway often becomes quite destructive (7).

Class III mutations disrupt activation and regulation of CFTR at the plasma membrane. Thus biosynthesis, trafficking, and processing are undisturbed, but the channel may be defective with respect to ATP binding and hydrolysis, or phosphorylation. Mutations, such as G551D, tend to be associated with a severe phenotype.

Class IV mutations affect chloride conductance or channel gating and thus result in reduced chloride current. As might be expected, mutations in this class, such as R117H or P574H, are thought to confer a milder phenotype.

Class V mutations reduce the level of normal CFTR protein by alterations in the promoter or by altering splicing. Currently it is thought that a reduction in mRNA to less than 10% of normal results in disease in CF. Examples of Class V mutations include 3849 + 10kb CT, A455E, and 5T.


Here's some info that Allie posted about how different classes "interact"...

Now, I know this is just one article, but I found it really interesting, in france, they did research of CFers with class I /I or class II/I combinations. They found a much higher likelihood of severe pancreatic disease (which we knew), but the interestig thing was they found that people with a class one mutation were more likely to be colonized with pseudo. Interesting.

<a target=_blank class=ftalternatingbarlinklarge href="http://www.pslgroup.com/dg/214BBE.htm">http://www.pslgroup.com/dg/214BBE.htm</a>

Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival .



Hope this helps.
 

CFHockeyMom

New member
First thing to note is that DF508 is the most common but it's class is not the most "severe". It is a class II mutation.

Here's some info I copied from another post about the various classes...

Class I mutations lead to defects in the synthesis of stable CFTR mRNA transcripts resulting in absence of the CFTR protein. About half of all mutations in CFTR (encompassing premature termination, exon skipping, aberrant mRNA splicing, and frameshifts) are thought to fall into this class and result in complete loss of CFTR protein/function.

Class II mutations, including F508, complete protein translation but produce an abnormal protein that fails to escape the endoplasmic reticulum. Little or no CFTR reaches the plasma membrane, and the absence of all surface CFTR results in a severe phenotype. It is being increasingly recognized that mutations in unrelated genes can create defective proteins, which fail to traffic properly through the cell. Classically, missense mutations creating an abnormal protein were thought to be relatively benign or less consequential than nonsense mutations (null) or large deletions. This is no longer strictly the case because examples from CF and other inherited disorders demonstrate that a synthesized protein that fails to mature along the normal biosynthetic pathway often becomes quite destructive (7).

Class III mutations disrupt activation and regulation of CFTR at the plasma membrane. Thus biosynthesis, trafficking, and processing are undisturbed, but the channel may be defective with respect to ATP binding and hydrolysis, or phosphorylation. Mutations, such as G551D, tend to be associated with a severe phenotype.

Class IV mutations affect chloride conductance or channel gating and thus result in reduced chloride current. As might be expected, mutations in this class, such as R117H or P574H, are thought to confer a milder phenotype.

Class V mutations reduce the level of normal CFTR protein by alterations in the promoter or by altering splicing. Currently it is thought that a reduction in mRNA to less than 10% of normal results in disease in CF. Examples of Class V mutations include 3849 + 10kb CT, A455E, and 5T.


Here's some info that Allie posted about how different classes "interact"...

Now, I know this is just one article, but I found it really interesting, in france, they did research of CFers with class I /I or class II/I combinations. They found a much higher likelihood of severe pancreatic disease (which we knew), but the interestig thing was they found that people with a class one mutation were more likely to be colonized with pseudo. Interesting.

<a target=_blank class=ftalternatingbarlinklarge href="http://www.pslgroup.com/dg/214BBE.htm">http://www.pslgroup.com/dg/214BBE.htm</a>

Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival .



Hope this helps.
 

LouLou

New member
RiRi, At the top of a section you'll see a space where you can enter a key word such as 'mutation' and press 'search' or you can go to 'advanced search' and do things like look for a post by a specific person.
 

LouLou

New member
RiRi, At the top of a section you'll see a space where you can enter a key word such as 'mutation' and press 'search' or you can go to 'advanced search' and do things like look for a post by a specific person.
 

LouLou

New member
RiRi, At the top of a section you'll see a space where you can enter a key word such as 'mutation' and press 'search' or you can go to 'advanced search' and do things like look for a post by a specific person.
 

Allie

New member
Claudette posted a lot of my stuff, but I'm the local genetics nerd if you have any questions. I'll do my best to answer them
 

Allie

New member
Claudette posted a lot of my stuff, but I'm the local genetics nerd if you have any questions. I'll do my best to answer them
 

Allie

New member
Claudette posted a lot of my stuff, but I'm the local genetics nerd if you have any questions. I'll do my best to answer them
 
Top